Cargando…
Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantation
Enzyme replacement therapy (ERT) has been introduced for Fabry disease and has been reported to clear some renal cell types of accumulated glycolipids and to reduce the accumulation in other cell types. We describe two patients without Fabry disease who were transplanted with kidney allografts from...
Autores principales: | Aasebø, Willy, Strøm, Erik H., Hovig, Torstein, Undset, Liv H., Heiberg, Arvid, Jenssen, Trond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477959/ https://www.ncbi.nlm.nih.gov/pubmed/28657066 http://dx.doi.org/10.1093/ndtplus/sfq036 |
Ejemplares similares
-
Kidney Transplant in Fabry Disease: A Revision of the Literature
por: Capelli, Irene, et al.
Publicado: (2020) -
Outcomes of Kidney Transplantation in Fabry Disease: A Meta-Analysis
por: Suarez, Maria L. Gonzalez, et al.
Publicado: (2020) -
Chronic kidney disease in patients with diabetes mellitus
por: Nordheim, Espen, et al.
Publicado: (2021) -
Angiomyolipoma of donor kidney: Successful transplantation and 5-year follow-up
por: Gopalakrishnan, N., et al.
Publicado: (2016) -
Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
por: Ussif, Amin M., et al.
Publicado: (2019)